Subsequently, overexpression of miR-30a inhibits the expression of Snail and Vimentin but promotes E-cadherin expression [31], which implies that miR-30a could enhance cisplatin sensitivity by inhibiting EMT in gastric cancer cells. The gene discussed is VIM; the disease is gastric cancer.